Search results for "COVID-19"


 
Results 91 - 100 of about 464 for "COVID-19".
Sort by: Relevance | Newest | Oldest

Monoclonal antibodies appear safe as COVID-19 treatment during pregnancy

Pregnant patients who received monoclonal antibody treatments had no higher risk for adverse obstetric events but also no significant improvement on COVID-19-related outcomes, a retrospective study found.
https://immattersacp.org/weekly/archives/2022/11/15/2.htm
15 Nov 2022

ACP, Annals of Internal Medicine host ninth forum on COVID-19

A full recording of COVID-19 Forum IX: Management of Patients with Persistent Symptoms after COVID-19 is available for replay online.
https://immattersacp.org/weekly/archives/2022/05/31/4.htm
31 May 2022

New ACP living practice points, mortality data on COVID-19

The College offered recommendations on outpatient COVID-19 treatments. Three studies looked at shifts in mortality from COVID-19 at different times and places. An international study compared infections in health care workers with medical masks versus N95s.
https://immattersacp.org/weekly/archives/2022/11/29/2.htm
29 Nov 2022

ACIP releases 2024 Adult Immunization Schedule featuring new vaccines

The latest recommendations from the Advisory Committee on Immunization Practices (ACIP) address vaccines against respiratory syncytial virus, mpox, COVID-19, and meningitis, among others.
https://immattersacp.org/weekly/archives/2024/01/16/1.htm
16 Jan 2024

New COVID-19 boosters authorized and recommended

The CDC has recommended the new formulations of the mRNA vaccines, targeted at the BA.4 and BA.5 lineages of the omicron variant, for adults and adolescents who last received a COVID-19 shot at least two months ago.
https://immattersacp.org/weekly/archives/2022/09/06/2.htm
6 Sep 2022

COVID-19 rebound occurs with or without antivirals, doesn't affect outcomes, studies find

Rebound of both COVID-19 symptoms and viral load was rare in untreated, unvaccinated outpatients, one study showed, while another found similar rates of viral rebound in patients treated with nirmatrelvir-ritonavir, molnupiravir, or neither antiviral.
https://immattersacp.org/weekly/archives/2023/02/21/2.htm
21 Feb 2023

‘Annals: Spotlight on 2023’ collection and video now available

The collection includes must-read articles on firearms, obesity, COVID-19, and more.
https://immattersacp.org/weekly/archives/2024/01/09/5.htm
9 Jan 2024

New COVID-19 vaccine authorized; reviews analyze myocarditis, drug treatments

The FDA gave the Novavax COVID-19 vaccine emergency use authorization for adults. One recent review found lower myocarditis risk with the Pfizer-BioNTech vaccine than the Moderna vaccine, and another looked at the strength of evidence supporting COVID-19 drug treatments.
https://immattersacp.org/weekly/archives/2022/07/19/4.htm
19 Jul 2022

CDC and FDA weigh in on safety of bivalent vaccine; research examines COVID-19 sequelae, omicron variants

The CDC and FDA said an observed association of ischemic stroke with the Pfizer-BioNTech bivalent booster is very unlikely to represent a true clinical risk. New studies reported on symptoms a year after mild COVID-19 and estimated protection against the omicron variants.
https://immattersacp.org/weekly/archives/2023/01/24/2.htm
24 Jan 2023

Fourth vaccine dose 62% effective against severe COVID-19 in month after receipt

Retrospective data from Israel showed that in people ages 60 years and older, an additional booster dose of the Pfizer-BioNTech COVID-19 vaccine was 55% effective against symptomatic disease and 68% effective against hospitalization.
https://immattersacp.org/weekly/archives/2022/04/19/4.htm
19 Apr 2022

Result Page: Prev   5   6   7   8   9   10   11   12   13   14   Next